mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-08 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0005 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0005 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.002 |